纳米医学
材料科学
阿霉素
PLGA公司
聚乙二醇
多重耐药
生物相容性
纳米颗粒
纳米技术
前药
药理学
有机化学
化学
医学
生物化学
化疗
抗生素
冶金
外科
作者
Jing Fan,Qianjun He,Yi Liu,Fuwu Zhang,Xiangyu Yang,Zhe Wang,Nan Lü,Wenpei Fan,Lisen Lin,Gang Niu,Nongyue He,Jibin Song,Xiaohong Chen
标识
DOI:10.1021/acsami.6b03737
摘要
Multidrug resistance (MDR) is responsible for the relatively low effectiveness of chemotherapeutics. Herein, a nitric oxide (NO) gas-enhanced chemosensitization strategy is proposed to overcome MDR by construction of a biodegradable nanomedicine formula based on BNN6/DOX coloaded monomethoxy(polyethylene glycol)–poly(lactic-co-glycolic acid) (mPEG-PLGA). On one hand, the nanomedicine features high biocompatibility due to the high density of PEG and biodegradable PLGA. On the other hand, the nanoformula exhibits excellent stability under physiological conditions but exhibits stimuli-responsive decomposition of BNN6 for NO gas release upon ultraviolet–visible irradiation. More importantly, after NO release is triggered, gas molecules are generated that break the nanoparticle shell and lead to the release of doxorubicin. Furthermore, NO was demonstrated to reverse the MDR of tumor cells and enhance the chemosensitization for doxorubicin therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI